Managing viral hepatitis requires addressing complex systemic barriers that prevent patients from accessing essential screening, immunisation, and antiviral care. On 28 July 2026, the World Health Organization leads the observance of World Hepatitis Day 2026 under the campaign theme, "Hepatitis: Let's Break It Down". This global initiative emphasizes dismantling the financial, clinical, and structural obstacles that delay care delivery and perpetuate rising mortality rates from chronic liver infection.

According to the World Health Organization's Global Hepatitis Report 2024, approximately 254 million individuals live with chronic hepatitis B and 50 million with chronic hepatitis C globally. This combined burden causes an estimated 1.3 million deaths annually, positioning viral hepatitis alongside tuberculosis as a leading infectious cause of death. Despite the availability of effective vaccines and curative oral antivirals, structural gaps in health systems continue to impede universal access.

Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, underscored the necessity of integrated public health action following the report's release.

"This report paints a troubling picture: despite progress globally in preventing hepatitis infections, deaths are rising because far too few people with hepatitis are being diagnosed and treated."

In India, national efforts have mobilized broad public health resources to counter the burden. Data from the WHO Global Hepatitis Report 2024 indicates that India accounts for 11.6% of the global burden, representing over 35 million chronic carriers of hepatitis B and C combined. Through the National Viral Hepatitis Control Programme launched in 2018, the government has expanded free screening, diagnosis, and antiviral treatment services nationwide. [Programme-level screening and treatment totals should be confirmed against the latest NVHCP/Ministry of Health figures before publication.]

However, clinicians emphasize that expanding diagnostic coverage remains critical to preventing long-term hepatic complications, particularly given how often chronic infections go unrecognized until advanced liver damage has already occurred.

Achieving global elimination by 2030 requires sustained public funding, decentralized diagnostic infrastructure, and continuous patient engagement across primary care networks.